Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)

Market Cap	11.93B -5.5%
Revenue (ttm)	2.42B +1.8%
Net Income	667.92M +19.2%
EPS	1.21 +14.5%
Shares Out	566.88M
PE Ratio	17.41
Forward PE	n/a
Dividend	0.38 (1.81%)
Ex-Dividend Date	n/a

Volume	2,598,497
Open	21.90
Previous Close	20.63
Day's Range	20.60 - 21.90
52-Week Range	20.51 - 38.16
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 24, 2026

About SHE:002287

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral tibetan medicines, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculoskeletal system, nervous system, respiratory, digestive, urinary, and cerebrovascular sectors. The company was founded in 1995 and is based in Nyingchi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 3,203
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002287

Financial Performance

In 2025, SHE:002287's revenue was 2.42 billion, an increase of 3.34% compared to the previous year's 2.34 billion. Earnings were 648.43 million, an increase of 11.36%.